Pfeil Keith W 的 Form 4/A 修正申報
修正Globus Medical Inc（GMED），2023/2/6 申報
- 申報編號
- 0001209191-23-007310
- 申報時間
- 2023/2/6
- 交易日
- 2021/8/19
- 申報延遲
- 536 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2021/8/23
這份申報列了 2 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $6.34 萬。交易後 536 天申報。
這份修正申報取代了 0001209191-21-052968（2021/8/23 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Pfeil Keith WCIK 0001752014 | 高階主管（資深副總裁、財務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/8/19 | Class A Common Stock | M行使選擇權取得 | +833 | $49.65F1 | +$41,358.45 | 833 | 直接 | |
| 2021/8/19 | Class A Common Stock | S賣出處分 | −833 | $76.13 | −$63,416.29 | 0 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/8/19 | Class A Common Stock | M行使選擇權處分 | −833 | $0.00 | $0 | 20,000 | 直接 | |
| 2021/8/19 | Class A Common Stock | M行使選擇權處分 | 0 | $0.00 | $0 | 24,167 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65.
表 I 有 1 筆交易的價格引用這則附註。
- F2
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
- F3
These options were granted on September 3, 2019 and are fully vested.
- F4
The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019.
- F5
These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.